Direxion Daily Pharmaceutical Etf Profile

PILL Etf  USD 5.30  0.29  5.79%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Direxion Daily is selling for 5.30 as of the 17th of May 2025. This is a 5.79 percent increase since the beginning of the trading day. The etf's lowest day price was 5.0. Direxion Daily has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of April 2025 and ending today, the 17th of May 2025. Click here to learn more.
The fund invests at least 80 percent of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. More on Direxion Daily Pharmaceutical

Moving together with Direxion Etf

  0.78SSO ProShares Ultra SP500PairCorr
  0.82SPXL Direxion Daily SP500PairCorr
  0.71QLD ProShares Ultra QQQPairCorr
  0.79NRGU Bank of MontrealPairCorr
  0.82UPRO ProShares UltraPro SP500PairCorr
  0.76TECL Direxion Daily TechnologyPairCorr

Moving against Direxion Etf

  0.57INDSX Financial Investors TrustPairCorr
  0.55WTID UBS ETRACSPairCorr
  0.54SDFI AB Active ETFs,PairCorr
  0.42FNGU MicroSectors FANG Index Symbol ChangePairCorr
  0.42EWZS iShares MSCI BrazilPairCorr
  0.31MSTY YieldMax MSTR OptionPairCorr

Direxion Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care ETFs, Sector ETFs, Trading--Leveraged Equity, Direxion Funds (View all Sectors)
IssuerDirexion
Inception Date2017-11-15
BenchmarkS&P Pharmaceuticals Select Industry Index
Entity TypeRegulated Investment Company
Asset Under Management12.85 Million
Average Trading Valume134,827.6
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorU.S. Bancorp Fund Services, LLC
AdvisorRafferty Asset Management, LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Portfolio ManagerPaul Brigandi, Tony Ng
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End30-Apr
ExchangeNYSE Arca, Inc.
Number of Constituents55.0
Market MakerIMC
Total Expense1.53
Management Fee0.75
Country NameUSA
Returns Y T D(25.15)
NameDirexion Daily Pharmaceutical Medical Bull 3X Shares ETF
Currency CodeUSD
Open FigiBBG00J7KDH95
In Threey Volatility52.97
1y Volatility46.1
200 Day M A7.5184
50 Day M A5.7488
CodePILL
Updated At17th of May 2025
Currency NameUS Dollar
Direxion Daily Pharmaceutical [PILL] is traded in USA and was established 2017-11-15. The fund is listed under Trading--Leveraged Equity category and is part of Direxion Funds family. The entity is thematically classified as Health Care ETFs. Direxion Daily Pharm at this time have 9.75 M in assets. , while the total return for the last 3 years was -18.6%.
Check Direxion Daily Probability Of Bankruptcy

Geographic Allocation (%)

Top Direxion Daily Pharmaceutical Etf Constituents

RPRXRoyalty Pharma PlcStockHealth Care
ABBVAbbVie IncStockHealth Care
SUPNSupernus PharmaceuticalsStockHealth Care
SAVACassava SciencesStockHealth Care
ELANElanco Animal HealthStockHealth Care
JAZZJazz Pharmaceuticals PLCStockHealth Care
BIIBBiogen IncStockHealth Care
MRKMerck CompanyStockHealth Care
More Details

Direxion Daily Pharm Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Direxion Daily. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

Direxion Daily Against Markets

When determining whether Direxion Daily Pharm is a strong investment it is important to analyze Direxion Daily's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Direxion Daily's future performance. For an informed investment choice regarding Direxion Etf, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Direxion Daily Pharmaceutical. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
The market value of Direxion Daily Pharm is measured differently than its book value, which is the value of Direxion that is recorded on the company's balance sheet. Investors also form their own opinion of Direxion Daily's value that differs from its market value or its book value, called intrinsic value, which is Direxion Daily's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Direxion Daily's market value can be influenced by many factors that don't directly affect Direxion Daily's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Direxion Daily's value and its price as these two are different measures arrived at by different means. Investors typically determine if Direxion Daily is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Direxion Daily's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.